We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$82.7B
1-Year Est. Return
28.53%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+28.53%
3 Year Est. Return
+81.04%
5 Year Est. Return
+81.98%
10 Year Est. Return
–
AUM
$56.1B
AUM Growth
+$6.71B
(+14%)
Cap. Flow
+$2.41B
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
25.67%
Holding
2,792
New
318
Increased
1,272
Reduced
940
Closed
166
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$215M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$201M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$184M |
| 4 |
Bank of America
BAC
|
+$168M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$161M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$97.6M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$73.8M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$62.6M |
| 5 |
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
|
+$60.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.79% |
| 2 | Financials | 8.41% |
| 3 | Healthcare | 6.12% |
| 4 | Industrials | 5% |
| 5 | Consumer Discretionary | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Gossamer Bio
GOSS
$75.8M
| $16.9K | ﹤0.01% |
13,761
| – | – |
|
2602
SES AI
SES
$222M
| $16.4K | ﹤0.01% |
18,501
+6,268
| +51% | +$5.26K |
|
2603
Invivyd
IVVD
$212M
| $14.9K | ﹤0.01% |
20,893
-18,400
| -47% | -$13.1K |
|
2604
Energy Vault
NRGV
$685M
| $13.6K | ﹤0.01% |
18,960
+5,524
| +41% | +$4.46K |
|
|
IGMS
2605
DELISTED
IGM Biosciences
IGMS
| $13.4K | ﹤0.01% |
11,923
-1,183
| -9% | -$1.45K |
|
2606
Context Therapeutics
CNTX
$48.9M
| $13.1K | ﹤0.01% |
20,000
+10,000
| +100% | +$7.19K |
|
2607
MacroGenics
MGNX
$258M
| $12.3K | ﹤0.01% |
+10,137
| New | +$14.7K |
|
2608
Solitario Resources
XPL
$75.4M
| $11.8K | ﹤0.01% |
18,100
| – | – |
|
2609
LanzaTech
LNZA
$68.5M
| $11.5K | ﹤0.01% |
+425
| New | +$10.4K |
|
|
TPIC
2610
DELISTED
TPI Composites
TPIC
| $10.8K | ﹤0.01% |
12,607
-6,913
| -35% | -$7.03K |
|
2611
Lineage Cell Therapeutics
LCTX
$273M
| $9.53K | ﹤0.01% |
+10,498
| New | +$6.23K |
|
|
APLT
2612
DELISTED
Applied Therapeutics
APLT
| $9.1K | ﹤0.01% |
29,243
-5,094
| -15% | -$1.97K |
|
2613
Ring Energy
REI
$360M
| $9K | ﹤0.01% |
+11,335
| New | +$9.6K |
|
|
ONCY
2614
Oncolytics Biotech
ONCY
$100M
| $7.73K | ﹤0.01% |
+10,000
| New | +$5.3K |
|
2615
Coherus Oncology
CHRS
$185M
| $7.72K | ﹤0.01% |
10,560
-44,116
| -81% | -$38.1K |
|
|
PRPH
2616
DELISTED
ProPhase Labs
PRPH
| $7.43K | ﹤0.01% |
1,900
-7,511
| -80% | -$25.1K |
|
2617
Rani Therapeutics
RANI
$90.6M
| $5.14K | ﹤0.01% |
10,000
| – | – |
|
2618
ADC Therapeutics
ADCT
$131M
| – | – |
-17,912
| Closed | -$25.3K |
|
2619
PUT
Automatic Data Processing
ADP
$108B
| – | – |
-238,918
| Closed | -$73M |
|
2620
Adtran
ADTN
$682M
| – | – |
-15,705
| Closed | -$137K |
|
2621
Acadia Realty Trust
AKR
$2.86B
| – | – |
-10,470
| Closed | -$219K |
|
2622
AMC Global Media
AMCX
$507M
| – | – |
-12,457
| Closed | -$85.7K |
|
2623
Arista Networks
ANET
$251B
| – | – |
-270,726
| Closed | -$23.4M |
|
2624
Applied Digital
APLD
$8.95B
| – | – |
-67,609
| Closed | -$380K |
|
|
ARI
2625
Apollo Commercial Real Estate
ARI
$877M
| – | – |
-11,634
| Closed | -$111K |
|
Similar funds
Cerity Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Cerity Partners held 2,792 positions worth $56.1B, up 14% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cerity Partners deployed $2.41B of net new capital in Q2 2025, opening 318 new positions and adding to 1,272 existing holdings. Its largest new stake was ExxonMobil: 2,014,446 shares worth $217M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $161M trimmed.
- Cerity Partners's largest Q2 2025 buy was ExxonMobil: 2,014,446 shares worth $217M.
- Cerity Partners added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $201M increase.
- Cerity Partners's biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $161M.
- Cerity Partners fully exited Discover Financial Services in Q2 2025, selling an estimated $33.9M.
- Cerity Partners's ten largest holdings make up 26% of its $56.1B portfolio in Q2 2025.
- Cerity Partners opened 318 new positions and closed 166 in Q2 2025.
- Cerity Partners's portfolio value rose 14% quarter-over-quarter to $56.1B.
Based on Cerity Partners's 13F filing for Q2 2025, filed 13 Aug 2025.